Paloma Partners’s Tandem Diabetes Care TNDM Stock Holding History

Paloma Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,993	Closed	-$464K	–	1748
2022 Q1	$464K	Buy	+3,993	New	+$466K	0.01%	813
2021 Q3	–	Sell	-5,922	Closed	-$577K	–	1863
2021 Q2	$577K	Buy	5,922 +1,619	+38%	+$144K	0.01%	931
2021 Q1	$380K	Buy	4,303 +1,574	+58%	+$146K	0.01%	1325
2020 Q4	$261K	Sell	2,729 -11,144	-80%	-$1.15M	0.01%	1236
2020 Q3	$1.57M	Sell	13,873 -88,407	-86%	-$9.29M	0.04%	477
2020 Q2	$10.1M	Buy	+102,280	New	+$8.16M	0.18%	105
2020 Q1	–	Sell	-29,002	Closed	-$1.73M	–	2055
2019 Q4	$1.73M	Sell	29,002 -4,832	-14%	-$298K	0.03%	654
2019 Q3	$2M	Buy	33,834 +20,432	+152%	+$1.3M	0.04%	432
2019 Q2	$864K	Buy	+13,402	New	+$865K	0.01%	768
2017 Q3	–	Sell	-10,548	Closed	-$84K	–	2425
2017 Q2	$84K	Buy	+10,548	New	+$97.5K	﹤0.01%	2087

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Paloma Partners's TNDM Position: Q2 2022 in Review

Paloma Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 3,993 shares — an estimated $464K sold.

Paloma Partners first reported a position in TNDM in Q2 2017 and held it in 10 quarters. The position peaked at $10.1M in Q2 2020. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Paloma Partners reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 3,993 Tandem Diabetes Care shares in Q2 2022, an estimated $464K.
Paloma Partners first reported a position in Tandem Diabetes Care in Q2 2017 and held it in 10 quarters.
Paloma Partners's Tandem Diabetes Care position peaked at $10.1M in Q2 2020.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.